110 related articles for article (PubMed ID: 9098476)
1. Treatment of female hyperandrogenism: estroprogestinic therapy at low dose in an inversal sequential scheme.
Ragonesi FP; Lo Mastro F; Arena V; Ermini M
Acta Eur Fertil; 1995; 26(4):141-3. PubMed ID: 9098476
[TBL] [Abstract][Full Text] [Related]
2. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
4. Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Vaidya RA; Shringi MS; Vaidya AB; Gogate JG
J Assoc Physicians India; 1997 Nov; 45(11):883-4. PubMed ID: 11229194
[No Abstract] [Full Text] [Related]
5. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
Luboshitzky R; Herer P; Shen-Orr Z
Neuro Endocrinol Lett; 2002 Aug; 23(4):309-13. PubMed ID: 12195232
[TBL] [Abstract][Full Text] [Related]
6. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Chung JP; Yiu AK; Chung TK; Chan SS
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
Garner PR; Poznanski N
J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
[TBL] [Abstract][Full Text] [Related]
8. Salivary testosterone as an index of antiandrogen therapy in hirsutism.
Gómez JM; Navarro MA; Arranz B; Soler J; Bonnin MR; Montaña E
Recenti Prog Med; 1992 Dec; 83(12):672-4. PubMed ID: 1494704
[TBL] [Abstract][Full Text] [Related]
9. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Franks S; Layton A; Glasier A
Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
[TBL] [Abstract][Full Text] [Related]
10. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
[TBL] [Abstract][Full Text] [Related]
11. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
Carmina E; Lobo RA
Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
[TBL] [Abstract][Full Text] [Related]
12. Cyproterone acetate for hirsutism.
Van der Spuy ZM; le Roux PA
Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Mueck AO;
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):170-171. PubMed ID: 28540758
[No Abstract] [Full Text] [Related]
14. [Hormonal treatment effectivity in hyperandrogenic syndrome].
Visnovský J; Biringer K; Svecová I; Biringerová Z
Ceska Gynekol; 2010 Oct; 75(5):481-5. PubMed ID: 21374929
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
16. [Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate].
Audebert A; Emperaire JC; Gauthier A; Hallonet P; Hedon B; Lopes P; Quereux C; Roulier R
Rev Fr Gynecol Obstet; 1991 Nov; 86(11):697-9. PubMed ID: 1838208
[TBL] [Abstract][Full Text] [Related]
17. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
Marianowski L; Cyganek A; Grzechocińska B
Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
[TBL] [Abstract][Full Text] [Related]
18. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Ibáñez L; Diaz M; Sebastiani G; Sánchez-Infantes D; Salvador C; Lopez-Bermejo A; de Zegher F
J Clin Endocrinol Metab; 2011 Nov; 96(11):3361-6. PubMed ID: 21865363
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
[TBL] [Abstract][Full Text] [Related]
20. [Acceptability, tolerance and quality of life impact of cyproterone acetate treatment in female hirsutism. Comparison of 2 protocols in combination with oral or transdermal estradiol].
Consoli SM; Vexiau P; Consoli SG; Abramovici Y
Contracept Fertil Sex; 1994 Dec; 22(12):783-7. PubMed ID: 7827642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
